- Report
- January 2024
- 26 Pages
Global
€15155EUR$17,150USD£13,352GBP
- Report
- January 2024
- 120 Pages
Global
From €5620EUR$6,360USD£4,951GBP
€7025EUR$7,950USD£6,189GBP
- Drug Pipelines
- July 2023
- 139 Pages
Global
From €13251EUR$14,995USD£11,674GBP
- Report
- July 2023
- 120 Pages
Global
From €3977EUR$4,500USD£3,503GBP
- Report
- July 2023
- 180 Pages
Global
From €3977EUR$4,500USD£3,503GBP
- Report
- July 2023
- 214 Pages
Global
From €3977EUR$4,500USD£3,503GBP
- Report
- April 2023
- 46 Pages
Global
From €4414EUR$4,995USD£3,889GBP
- Report
- February 2023
- 243 Pages
Asia Pacific
From €4904EUR$5,550USD£4,321GBP
- Report
- November 2022
- 31 Pages
Global
€10825EUR$12,250USD£9,537GBP
- Report
- January 2022
- 148 Pages
Global
From €3756EUR$4,250USD£3,309GBP
From €3756EUR$4,250USD£3,309GBP
- Report
- September 2021
- 19 Pages
Thailand
From €825EUR$1,000USD£752GBP
- Report
- November 2018
- 53 Pages
Global
From €7507EUR$8,495USD£6,614GBP
- Report
- June 2018
- 16 Pages
Global
From €8837EUR$10,000USD£7,785GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €353EUR$400USD£311GBP
€442EUR$500USD£389GBP
- Report
- December 2022
- 42 Pages
Global
From €3093EUR$3,500USD£2,725GBP
- Report
- December 2022
- 69 Pages
Global
From €1767EUR$2,000USD£1,557GBP
- Report
- November 2022
- 47 Pages
Global
From €1767EUR$2,000USD£1,557GBP
- Report
- November 2022
- 40 Pages
Global
From €1767EUR$2,000USD£1,557GBP
- Report
- November 2022
- 67 Pages
Global
From €3093EUR$3,500USD£2,725GBP

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups.
The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products.
Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more